# An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH

> **NCT02545101** · — · COMPLETED · sponsor: **Otsuka Pharmaceutical Europe Ltd** · enrollment: 100 (actual)

## Conditions studied

- Hyponatremia
- Syndrome of Inappropriate ADH (SIADH) Secretion

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02545101
- **Lead sponsor:** Otsuka Pharmaceutical Europe Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2018-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02545101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02545101, "An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02545101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*